Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidermal Nerve Fibre Density Reduction with Topical Capsaicin
DRKS00004587Phase 4Completed
- Sponsor
- University Hospital Vienna
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of capsaicin (3 arms), sponsored by University Hospital Vienna. Primary endpoint: Epidermal nerve fibre density reduction. Started Dec 2012; status: completed.
02
Drugs
capsaicin
Beyond the preview
Go deeper on DRKS00004587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004587.